mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
-0.03 |
0.5 |
mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.5 |
mRNA |
BRD-K41597374 |
CTRPv2 |
pan-cancer |
AAC |
0.029 |
0.5 |
mRNA |
BRD-K30748066 |
CTRPv2 |
pan-cancer |
AAC |
-0.092 |
0.5 |
mRNA |
tacrolimus |
CTRPv2 |
pan-cancer |
AAC |
-0.029 |
0.5 |
mRNA |
BRD-K34099515 |
CTRPv2 |
pan-cancer |
AAC |
0.067 |
0.5 |
mRNA |
AM-580 |
CTRPv2 |
pan-cancer |
AAC |
-0.03 |
0.5 |
mRNA |
SNS-032 |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.5 |
mRNA |
selumetinib:vorinostat (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.5 |
mRNA |
pifithrin-mu |
CTRPv2 |
pan-cancer |
AAC |
-0.027 |
0.5 |